# Pan European Collaboration on Antipsychotic Naïve Schizophrenia II

> **NCT02339844** · PHASE4 · COMPLETED · sponsor: **University of Copenhagen** · enrollment: 130 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT02339844
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2021-01
- **Final completion:** 2021-01
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02339844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02339844, "Pan European Collaboration on Antipsychotic Naïve Schizophrenia II". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02339844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*